Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Immunotherapy and personalised medicine in review

Prof Paul Sondel - University of Wisconsin, Madison, USA
Immunotherapy and personalised medicine in review ( Prof Paul Sondel - University of Wisconsin, Madison, USA )
4 Apr 2016

Treating childhood brainstem cancer using nanotechnology

Dr Dannis Van Vuurden - VU University Medical Center, Amsterdam, The Netherlands
Treating childhood brainstem cancer using nanotechnology ( Dr Dannis Van Vuurden - VU University Medical Center, Amsterdam, The Netherlands )
8 Feb 2016

Molecular drug imaging to guide brain cancer therapy

Dr Dannis Van Vuurden - VU University Medical Center, Amsterdam, The Netherlands
Molecular drug imaging to guide brain cancer therapy ( Dr Dannis Van Vuurden - VU University Medical Center, Amsterdam, The Netherlands )
8 Feb 2016

Complementary drug delivery techniques for interstitial administration

Dr Ruman Rahman - University of Nottingham, Nottingham, UK
Complementary drug delivery techniques for interstitial administration ( Dr Ruman Rahman - University of Nottingham, Nottingham, UK )
4 Feb 2016

Editor's choice for January 2016

Prof Gordon McVie - ecancer Editor
Editor's choice for January 2016 ( Prof Gordon McVie - ecancer Editor )
2 Feb 2016

Subgroup analyses of METEOR; randomized phase III trial of cabozantinib vs everolimus for RCC

Prof Bernard Escudier - Institut Gustave-Roussy, Paris, France
Subgroup analyses of METEOR; randomized phase III trial of cabozantinib vs everolimus for RCC ( Prof Bernard Escudier - Institut Gustave-Roussy, Paris, France )
8 Jan 2016

Discontinuing VEGF-targeted therapy for progression or toxicity affects outcomes of second-line therapies in mRCC

Dr Guillermo de Velasco - Dana-Farber Cancer Institute, Boston, USA
Discontinuing VEGF-targeted therapy for progression or toxicity affects outcomes of second-line therapies in mRCC ( Dr Guillermo de Velasco - Dana-Farber Cancer Institute, Boston, USA )
8 Jan 2016

Molecular genetics of testicular cancer: What does the clinician need to know?

Dr Katherine Nathanson - University of Pennsylvania, Philadelphia, USA
Molecular genetics of testicular cancer: What does the clinician need to know? ( Dr Katherine Nathanson - University of Pennsylvania, Philadelphia, USA )
8 Jan 2016

Actionable targets in patients with cisplatin-resistant advanced germ cell tumours

Dr Aditya Bagrodia - Memorial Sloan Kettering New York, USA
Actionable targets in patients with cisplatin-resistant advanced germ cell tumours ( Dr Aditya Bagrodia - Memorial Sloan Kettering New York, USA )
7 Jan 2016

The DNA damage response

Dr Helge Gad - Karolinska Institutet, Stockholm, Sweden
The DNA damage response ( Dr Helge Gad - Karolinska Institutet, Stockholm, Sweden )
22 Dec 2015

From genotype to molecular phenotype by proteomics

Dr Janne Lehtiö - Karolinska Institutet, Stockholm, Sweden
From genotype to molecular phenotype by proteomics ( Dr Janne Lehtiö - Karolinska Institutet, Stockholm, Sweden )
22 Dec 2015

TAILORx: Genomic test helps identify low-risk women who do not need chemotherapy

Dr Virginia Kaklamani - UT Health Science Center, San Antonio, TX
TAILORx: Genomic test helps identify low-risk women who do not need chemotherapy ( Dr Virginia Kaklamani - UT Health Science Center, San Antonio, TX )
17 Dec 2015